NORTHERN TRUST CORP - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 28 filers reported holding ARCA BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$42,174
-1.0%
20,9820.0%0.00%
Q2 2023$42,593
+2.0%
20,9820.0%0.00%
Q1 2023$41,754
+0.6%
20,982
+19.8%
0.00%
Q4 2022$41,515
+15.3%
17,5170.0%0.00%
Q3 2022$36,000
-18.2%
17,5170.0%0.00%
Q2 2022$44,000
+10.0%
17,5170.0%0.00%
Q1 2022$40,000
+5.3%
17,5170.0%0.00%
Q4 2021$38,000
-26.9%
17,5170.0%0.00%
Q3 2021$52,000
-14.8%
17,5170.0%0.00%
Q2 2021$61,000
-4.7%
17,5170.0%0.00%
Q1 2021$64,000
-8.6%
17,517
-0.0%
0.00%
Q4 2020$70,00017,5250.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 706,930$1,406,7911.22%
Newtyn Management, LLC 519,765$1,034,3320.20%
Murchinson Ltd. 52,800$100,6800.01%
Marquette Asset Management, LLC 17,318$34,4630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$93,4270.00%
Tekla Capital Management LLC 32,461$64,5970.00%
OSAIC HOLDINGS, INC. 57$1130.00%
DIMENSIONAL FUND ADVISORS LP 42,502$84,5790.00%
Parallel Advisors, LLC 244$4860.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
View complete list of ARCA BIOPHARMA INC shareholders